Seegene Usa, Inc.
Irvine, CA Doing business as Seegene USA Inc. Sales
- UEI
- YDDKWNE9JAY7
- CAGE
- 7NPS3
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 141 Innovation Dr #200, Irvine, CA 92617, USA
- Website
- seegene.com
- Founded
- 2000
- Employees
- 251-1K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| EO 14398: novaplex system | CDC Pittsburgh | $121,950 | |
| Novaplex HPV28 detection kit purchase | CDC Pittsburgh | $57,490 | |
| HPV detection RUO assay | CDC Pittsburgh | $85,500 | |
| Seegene novaplex | CDC Pittsburgh | $72,000 | |
| Lab supplies - reagents for HPV test kits | CDC Pittsburgh | $65,375 |
About Seegene Usa, Inc.
Seegene USA Inc. is a foreign-owned, for-profit small disadvantaged business registered in SAM.gov, with corporate headquarters located in Irvine, California. The company is structured as a Subchapter S Corporation and specializes in molecular diagnostic products and laboratory testing technologies, with a specific focus on HPV (human papillomavirus) detection and screening solutions. While detailed information about the company's full background is not provided, the federal contract award history indicates that Seegene USA Inc. Sales Division is primarily engaged in providing advanced diagnostic reagents and molecular testing kits to federal health agencies.
Seegene USA Inc. has exclusively been awarded federal contracts with the Centers for Disease Control and Prevention (CDC) in Pittsburgh, focusing on supplying specialized laboratory equipment and diagnostic reagents. These contracts, ranging from $57,490 to $85,500, have consistently involved the procurement of NOVAPLEX HPV28 Detection Kits, HPV Detection RUO Assays, and related molecular diagnostic reagents. The contracts have been firm fixed-price purchase orders without specific set-aside designations, supporting the CDC's public health mission related to HPV screening and prevention. The company's contract history demonstrates a recurring relationship with the CDC, with awards spanning from 2020 to 2025, indicating a consistent capability to provide high-quality diagnostic testing products for public health research and screening purposes. The contracts have been primarily centered on laboratory supplies, reagents, and specialized molecular diagnostic kits designed for HPV testing and research.
Quick answers
What is Seegene Usa, Inc.'s UEI?
Seegene Usa, Inc.'s Unique Entity ID (UEI) in SAM.gov is YDDKWNE9JAY7.
What is Seegene Usa, Inc.'s CAGE code?
Seegene Usa, Inc.'s CAGE code is 7NPS3.
What is Seegene Usa, Inc.'s primary NAICS code?
Seegene Usa, Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Where is Seegene Usa, Inc. located?
Seegene Usa, Inc.'s physical address in SAM.gov is 141 Innovation Dr #200, Irvine, CA 92617, USA.
Is Seegene Usa, Inc. registered in SAM.gov?
Yes. Seegene Usa, Inc.'s SAM.gov registration is active through March 9, 2027.
What is Seegene Usa, Inc.'s most recent federal award?
Seegene Usa, Inc.'s most recent federal contract award is EO 14398: novaplex system (75D30126P21232), from CDC Pittsburgh, on August 6, 2026.
On GovTribe
See Seegene Usa, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors